Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells directly within the patient's body. Its lead drug product candidate is CUE-101 for the treatment of human papilloma virus (HPV16+)-driven recurrent/metastatic head and neck cancer. The company is also developing CUE-102 targets Wilms' Tumor 1 protein in various cancers; CUE-103, a CUE-100 series drug product candidate; and Neo-STAT and RDI-STAT programs outside of oncology, including CUE-200, CUE-300, and CUE-400 series. It has collaboration agreements with LG Chem, Ltd. for the development of Immuno-STATs focused in the field of oncology; strategic collaboration and option agreement with Ono Pharmaceutical Co., Ltd. to advance CUE-401 for the treatment of autoimmune and inflammatory diseases; and license agreement with Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Cue Biopharma Inc.

An update from Cue Energy Resources Limited ( ($AU:CUE) ) is now available. Cue Energy Resources has issued a supplementary target’s statement in r...

Cue Energy Urges Rejection of Horizon Bid as New NT Gas Deal Boosts Outlook

Cue Biopharma ( ($CUE) ) has shared an announcement. At its April 13, 2026 annual meeting, Cue Biopharma stockholders elected six directors, includ...

Cue Biopharma Shareholders Approve Reverse Stock Split Flexibility

An announcement from Cue Energy Resources Limited ( ($AU:CUE) ) is now available. The Takeovers Panel has declined to conduct proceedings on an app...

Takeovers Panel Rejects Cue Energy Challenge to Horizon Oil Bid

Cue Energy Resources Limited ( ($AU:CUE) ) has provided an announcement. The Takeovers Panel has accepted an undertaking from Echelon Resources Lim...

Echelon Agrees to Delay Accepting Horizon’s Takeover Bid for Cue Energy

Cue Biopharma ( ($CUE) ) has shared an announcement. On April 1, 2026, Cue Biopharma, Inc. reported that Boehringer Ingelheim selected its first co...

Cue Biopharma Reaches Key Preclinical Milestone With Boehringer

Cue Energy Resources Limited ( ($AU:CUE) ) has provided an announcement. Cue Energy Resources has begun distributing its target’s statement to shar...

Cue Energy dispatches target’s statement on Horizon Oil takeover bid

The latest announcement is out from Cue Energy Resources Limited ( ($AU:CUE) ). Cue Energy Resources has issued a target’s statement in response to...

Cue Energy Board Urges Shareholders to Reject Horizon Oil Takeover Bid

Cue Energy Resources Limited ( ($AU:CUE) ) has provided an announcement. Horizon Oil and its Mereenie Joint Venture partners have secured an extens...

Horizon Oil Wins Extension to Finalise Mereenie Gas Sales Deal

Cuentas ( ($CUEN) ) has released a notification of late filing. Cuentas, Inc. has filed a Form 12b-25 notifying investors of a delay in submitting ...

Cuentas Delays Annual 10-K Yearly Filing

The latest announcement is out from Cue Biopharma ( ($CUE) ). On March 26, 2026, Cue Biopharma’s board appointed Chief Financial and Business Offic...

Cue Biopharma Names Lucinda Warren Interim Chief Executive

Cue Energy Resources Limited ( ($AU:CUE) ) has provided an update. Horizon Oil Limited, an ASX-listed oil and gas producer, has launched an off-mar...

Horizon Oil Clears Minimum Bid Price Hurdle in Cue Energy Takeover Offer

Cue Energy Resources Limited ( ($AU:CUE) ) has provided an update. Horizon Oil and its Mereenie Joint Venture partners have reached an agreement wi...

Horizon Oil Extends Deadline for Mereenie Gas Sales Agreement

The latest announcement is out from Cue Energy Resources Limited ( ($AU:CUE) ). Cue Energy Resources has confirmed that Horizon Oil has dispatched ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CUE	$0.61	-1.46%	2.91M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CUE	$0.61	-1.5%	2.91M
3
4
5
6

CUE

CUE

Get Cue Biopharma Inc. Data in Excel

Get Cue Biopharma Inc. Data in Excel